108 related articles for article (PubMed ID: 10833425)
1. CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity.
Jekle A; Obst R; Lang F; Rammensee HG; Gulbins E
Biochem Biophys Res Commun; 2000 Jun; 272(2):395-9. PubMed ID: 10833425
[TBL] [Abstract][Full Text] [Related]
2. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
Ehl S; Hoffmann-Rohrer U; Nagata S; Hengartner H; Zinkernagel R
J Immunol; 1996 Apr; 156(7):2357-60. PubMed ID: 8786290
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects on the inhibition of human CD8+ cytotoxic T lymphocytes-mediated killing against xenograft cells by coexpression of membrane-bound Human FasL and decoy Fas antigen.
Tanemura M; Kawamoto K; Ito T; Uchikoshi F; Shimada K; Nishida T; Matsuda H
Transplant Proc; 2005 Dec; 37(10):4607-9. PubMed ID: 16387181
[TBL] [Abstract][Full Text] [Related]
4. CD95-dependent bystander lysis caused by CD4+ T helper 1 effectors.
Wang R; Rogers AM; Ratliff TL; Russell JH
J Immunol; 1996 Oct; 157(7):2961-8. PubMed ID: 8816403
[TBL] [Abstract][Full Text] [Related]
5. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis.
Chattergoon MA; Kim JJ; Yang JS; Robinson TM; Lee DJ; Dentchev T; Wilson DM; Ayyavoo V; Weiner DB
Nat Biotechnol; 2000 Sep; 18(9):974-9. PubMed ID: 10973219
[TBL] [Abstract][Full Text] [Related]
6. The regulation of CD95 ligand expression and function in CTL.
Li JH; Rosen D; Ronen D; Behrens CK; Krammer PH; Clark WR; Berke G
J Immunol; 1998 Oct; 161(8):3943-9. PubMed ID: 9780162
[TBL] [Abstract][Full Text] [Related]
7. T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas.
Sayers TJ; Brooks AD; Seki N; Smyth MJ; Yagita H; Blazar BR; Malyguine AM
J Leukoc Biol; 2000 Jul; 68(1):81-6. PubMed ID: 10914493
[TBL] [Abstract][Full Text] [Related]
8. CD95 (APO-1/Fas) and its ligand in the mouse immune system.
Mariani SM; Matiba B; Krammer PH
Behring Inst Mitt; 1996 Oct; (97):12-23. PubMed ID: 8950464
[No Abstract] [Full Text] [Related]
9. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
Rich RF; Cook WJ; Green WR
Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
[TBL] [Abstract][Full Text] [Related]
10. Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity.
Strauss G; Osen W; Knape I; Jacobsen EM; Müller SM; Debatin KM
Cell Death Differ; 2007 Mar; 14(3):480-8. PubMed ID: 16902496
[TBL] [Abstract][Full Text] [Related]
11. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-alpha.
Shinbori T; Walczak H; Krammer PH
Eur J Immunol; 2004 Jun; 34(6):1762-70. PubMed ID: 15162447
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.
Perabo FG; Kamp S; Schmidt D; Lindner H; Steiner G; Mattes RH; Wirger A; Pegelow K; Albers P; Kohn EC; von Ruecker A; Mueller SC
Br J Cancer; 2001 May; 84(10):1330-8. PubMed ID: 11355943
[TBL] [Abstract][Full Text] [Related]
13. Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells.
Zhang HG; Liu D; Heike Y; Yang P; Wang Z; Wang X; Curiel DT; Zhou T; Mountz JD
Nat Biotechnol; 1998 Nov; 16(11):1045-9. PubMed ID: 9831033
[TBL] [Abstract][Full Text] [Related]
14. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis.
Bonetti B; Valdo P; Ossi G; De Toni L; Masotto B; Marconi S; Rizzuto N; Nardelli E; Moretto G
Glia; 2003 Aug; 43(2):141-8. PubMed ID: 12838506
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
16. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
[TBL] [Abstract][Full Text] [Related]
17. The T cell death knell: immune-mediated tumor death in renal cell carcinoma.
Uzzo RG; Kolenko V; Froelich CJ; Tannenbaum C; Molto L; Novick AC; Bander NH; Bukowski R; Finke JH
Clin Cancer Res; 2001 Oct; 7(10):3276-81. PubMed ID: 11595725
[TBL] [Abstract][Full Text] [Related]
18. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
19. Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes.
Hallermalm K; De Geer A; Kiessling R; Levitsky V; Levitskaya J
Cancer Res; 2004 Sep; 64(18):6775-82. PubMed ID: 15374996
[TBL] [Abstract][Full Text] [Related]
20. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.
Chakraborty M; Abrams SI; Coleman CN; Camphausen K; Schlom J; Hodge JW
Cancer Res; 2004 Jun; 64(12):4328-37. PubMed ID: 15205348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
